JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB201061

Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Recombinant
  • What is this?

5

(6 Reviews)

|

(12 Publications)

Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (ab201061) is a rabbit monoclonal antibody detecting beta Amyloid 1-42 in IHC-P, Dot Blot. Suitable for Human, Mouse.

- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications

View Alternative Names

A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)

IHC image of beta Amyloid 1-42 staining in human Alzheimer hippocampus formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab201062, 1μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre

Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)
  • Dot

Supplier Data

Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)

Dot blot analysis of beta Amyloid 1-42 labeled with ab201061 at 1/10000 dilution.
Lane 1 : beta Amyloid (Aβ) 1-40.
Lane 2 : beta Amyloid (Aβ) 1-42.
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/5000 dilution was used as secondary antibody.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.

Antibody reactivity was assessed using a dot blot, which is a non-quantitative method that maintains the native conformation of beta Amyloid. Beta Amyloid 1-40 and 1-42 peptides underwent the following aggregation conditions before being spotted onto a nitrocellulose membrane and detected using ab201061 :
Monomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 1% SDS and boiled for five minutes.
Oligomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 10 mM phosphate buffer pH 7.4 containing 0.02% sodium azide and incubated at room temperature for four days.
Fibrils : 0.3 mg of beta Amyloid peptide was dissolved in 1 ml 50% hexafluoroisopropanol (HFIP) with 0.02% sodium azide. It was then stirred constantly for nine days; the first seven with a cap on and the final two with the cap removed to allow evaporation of the HFIP. Fibrils were then sedimented at 20,000 rpm in a microcentrifuge for 20 minutes and resuspended in 1 ml of PBS + 0.02% sodium azide.

Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)
  • Dot

Supplier Data

Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)

Negative control (secondary ab only) :

Lane 1 : beta Amyloid (Aβ) 1-40.
Lane 2 : beta Amyloid (Aβ) 1-42.

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/5000 dilution was used as secondary antibody.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.

  • Carrier free

    Anti-beta Amyloid 1-42 antibody [mOC98] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

mOC98

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

Dot, IHC-P

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "" }, "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/10000", "Dot-species-notes": "<p></p>" } } }

You may be interested in:

AB150663

Congo Red Stain Kit (Amyloid Stain)

0

0 Reviews

View product

We recommend this product because it’s often used in the same experiment or related research.

We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.

Product details

What is this antibody validated in?
Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (ab201061) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Dot Blot in Human, Mouse samples.

Trusted by the scientific community
Anti-beta Amyloid 1-42 [mOC98] - Conformation-Specific (ab201061) was first used in a scientific publication in 2015 and has been cited over 10 times in peer-reviewed journals.

Reviewed by scientists
Anti-beta Amyloid 1-42 [mOC98] - Conformation-Specific (ab201061) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [mOC98] also available for your convenience: ab201061, Carrier free - ab240360

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Beta Amyloid 1-42 often referred to as Abeta 42 or amyloid beta 1-42 is a peptide derived from the amyloid precursor protein (APP). This peptide consists of 42 amino acids and has a molecular weight of approximately 4.5 kDa. It is predominantly found in the brain especially within regions associated with memory and cognitive function. Beta amyloid 1-42 is a product of enzymatic cleavage by beta and gamma secretases from the larger APP molecule. Due to its aggregation-prone nature beta amyloid 1-42 is a focus in neuroscience research particularly concerning the formation of amyloid plaques.
Biological function summary

Amyloid beta 1-42 plays a central role in synaptic activity and neuronal health. While not inherently pathogenic its tendency to aggregate forms oligomers and fibrils which become toxic to neurons. This peptide contributes to synaptic dysfunction and neuronal cell death and is a major component of extracellular amyloid plaques found in brain tissue. Within the cellular environment amyloid beta 1-42 can interact with receptors membrane lipids and intracellular signaling mechanisms thereby affecting neuronal cell function.

Pathways

Amyloid beta 1-42 is important in the amyloidogenic pathway which is one of the critical components in APP processing. The pathway includes proteolytic enzymes like beta secretase (BACE1) and gamma secretase where misregulation may lead to excessive production or deposition of amyloid beta peptides. Another related pathway is the tau protein phosphorylation pathway which indirectly interacts with amyloid beta 1-42 due to shared signaling intermediates impacting tau stabilization and microtubule assembly in neurons.

Amyloid beta 1-42 plays a pivotal role in Alzheimer's disease a prevalent neurodegenerative disorder. The excessive accumulation of beta amyloid in the form of plaques is a hallmark of the disease contributing to cognitive decline. Also it has links to cerebral amyloid angiopathy where it deposits in the walls of blood vessels of the central nervous system. Both conditions may involve interactions with tau protein another pathological feature of Alzheimer's disease which undergoes hyperphosphorylation leading to neurofibrillary tangles formation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed : 25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed : 17062754, PubMed : 23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.. Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.. Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain.. The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.
See full target information APP

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in aging neuroscience 15:1250342 PubMed37810621

2023

Long-term social isolation stress exacerbates sex-specific neurodegeneration markers in a natural model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Carolina A Oliva,Matías Lira,Claudia Jara,Alejandra Catenaccio,Trinidad A Mariqueo,Carolina B Lindsay,Francisco Bozinovic,Grisel Cavieres,Nibaldo C Inestrosa,Cheril Tapia-Rojas,Daniela S Rivera

Cell communication and signaling : CCS 21:91 PubMed37143104

2023

mTOR-dependent TFEB activation and TFEB overexpression enhance autophagy-lysosome pathway and ameliorate Alzheimer's disease-like pathology in diabetic encephalopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Lizhen Cheng,Yixin Chen,Donghao Guo,Yuan Zhong,Wei Li,Yijia Lin,Ya Miao

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e22734 PubMed36583697

2022

ADAM10- and γ-secretase-dependent cleavage of the transmembrane protein PTPRT attenuates neurodegeneration in the mouse model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Siling Liu,Zhongyu Zhang,Lianwei Li,Li Yao,Zhanshan Ma,Jiali Li

FEBS letters 597:1007-1040 PubMed36448495

2022

Senile plaques in Alzheimer's disease arise from Aβ- and Cathepsin D-enriched mixtures leaking out during intravascular haemolysis and microaneurysm rupture.

Applications

Unspecified application

Species

Unspecified reactive species

Hualin Fu,Jilong Li,Peng Du,Weilin Jin,Guo Gao,Daxiang Cui

PloS one 17:e0262224 PubMed35143502

2022

Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Jung-In Lee,Ji Sun Lim,Jeong-Ho Hong,Shin Kim,Sang-Woo Lee,Hyun Dong Ji,Kyoung Sook Won,Bong-Il Song,Hae Won Kim

Scientific reports 11:15934 PubMed34354200

2021

Novel blood test for early biomarkers of preeclampsia and Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Shibin Cheng,Sayani Banerjee,Lori A Daiello,Akitoshi Nakashima,Sukanta Jash,Zheping Huang,Jonathan D Drake,Jan Ernerudh,Goran Berg,James Padbury,Shigeru Saito,Brian R Ott,Surendra Sharma

Behavioural neurology 2021:6683318 PubMed33880134

2021

High Methionine Diet-Induced Alzheimer's Disease like Symptoms Are Accompanied by 5-Methylcytosine Elevated Levels in the Brain.

Applications

Unspecified application

Species

Unspecified reactive species

Tingting Pi,Shenjiao Wei,Yongxuan Jiang,Jing-Shan Shi

FEBS open bio 11:146-163 PubMed33185010

2020

Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer's disease rats.

Applications

Unspecified application

Species

Unspecified reactive species

Myrthe Mampay,María Velasco-Estevez,Sara O Rolle,Aisling M Chaney,Hervé Boutin,Kumlesh K Dev,Emad Moeendarbary,Graham K Sheridan

Frontiers in aging neuroscience 10:332 PubMed30405400

2018

Infection Augments Expression of Mechanosensing Piezo1 Channels in Amyloid Plaque-Reactive Astrocytes.

Applications

IHC

Species

Rat

María Velasco-Estevez,Myrthe Mampay,Hervé Boutin,Aisling Chaney,Peter Warn,Andrew Sharp,Ellie Burgess,Emad Moeendarbary,Kumlesh K Dev,Graham K Sheridan

International journal of Alzheimer's disease 2018:1672568 PubMed30034864

2018

Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42.

Applications

Unspecified application

Species

Unspecified reactive species

Aristo Vojdani,Elroy Vojdani
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Product
Primary Antibodies

AB224026

Alexa Fluor® 488 Anti-beta Amyloid 1-42 antibody [mOC64]

primary-antibodies

alexa-fluor-488-beta-amyloid-1-42-antibody-moc64-ab224026

0

(0 reviews)

Alternative Product
Primary Antibodies

AB201060

Anti-beta Amyloid 1-42 antibody [mOC64]

primary-antibodies

beta-amyloid-1-42-antibody-moc64-ab201060

5

(8 reviews)

Alternative Product
Primary Antibodies

AB240233

Anti-beta Amyloid 1-42 antibody [EPR9296] - BSA and Azide free

primary-antibodies

beta-amyloid-1-42-antibody-epr9296-bsa-and-azide-free-ab240233

0

(0 reviews)

Alternative Product
Primary Antibodies

AB271968

Anti-beta Amyloid 1-42 antibody [mOC64] - BSA and Azide free

primary-antibodies

beta-amyloid-1-42-antibody-moc64-bsa-and-azide-free-ab271968

0

(0 reviews)

Alternative Product
Primary Antibodies

AB224275

Anti-beta Amyloid 1-42 antibody [mOC64] - Low endotoxin, Azide free

primary-antibodies

beta-amyloid-1-42-antibody-moc64-low-endotoxin-azide-free-ab224275

0

(0 reviews)

Alternative Product
Primary Antibodies

AB205340

Anti-beta Amyloid antibody [mOC23] - Conformation-Specific

primary-antibodies

beta-amyloid-antibody-moc23-conformation-specific-ab205340

4

(1 reviews)

Alternative Product
Primary Antibodies

AB180956

Anti-beta Amyloid 1-42 antibody [EPR9296]

primary-antibodies

beta-amyloid-1-42-antibody-epr9296-ab180956

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com